Market Value7,216,744,000
Total Holdings95
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARYE / ARYA Sciences Acquisition Corp V - Class A
ARDX / Ardelyx, Inc.
IMGN / ImmunoGen, Inc.
CLDX / Celldex Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
TNYA / Tenaya Therapeutics, Inc.
BOLT / Bolt Biotherapeutics, Inc.
TXMD / TherapeuticsMD, Inc.
SYBX / Synlogic, Inc.
TYRA / Tyra Biosciences, Inc.
AXSM / Axsome Therapeutics, Inc.
FVAM / 5:01 Acquisition Corp.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
CTKB / Cytek Biosciences, Inc.
GHRS / GH Research PLC
TNGX / Tango Therapeutics, Inc.
RPHM / Reneo Pharmaceuticals, Inc.
/ Cue Health, Inc.
PRDS / Pardes Biosciences Inc
FLACU / Frazier Lifesciences Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
/ Nautilus Biotechnology Inc
AKUS / Akouos Inc
HLXA / Helix Acquisition Corp - Class A
/ Therapeutics Acquisition Corp. Class A
ARYD / ARYA Sciences Acquisition Corp IV
ORIC / ORIC Pharmaceuticals, Inc.
SCPH / scPharmaceuticals Inc.
JANX / Janux Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
VERV / Verve Therapeutics, Inc.
OTIC / Otonomy Inc
CVRX / CVRx, Inc.
TIL / Instil Bio, Inc.
CGEM / Cullinan Therapeutics, Inc.
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
NTLA / Intellia Therapeutics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
RXST / RxSight, Inc.
CTMX / CytomX Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
PNT / POINT Biopharma Global Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
/ Cerevel Therapeutics Holdings, Inc. Warrant
HOWL / Werewolf Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
GRPH / Graphite Bio, Inc.
IKNA / Ikena Oncology, Inc.
IVVD / Invivyd, Inc.
SPRY / ARS Pharmaceuticals, Inc.
MIST / Milestone Pharmaceuticals Inc.
INZY / Inozyme Pharma, Inc.
CRIS / Curis, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
PHAS / PhaseBio Pharmaceuticals Inc
TRIL / Trillium Therapeutics Inc
AVIR / Atea Pharmaceuticals, Inc.
ETNB / 89bio, Inc.
BMEA / Biomea Fusion, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
ENTX / Entera Bio Ltd.
SLDB / Solid Biosciences Inc.
HSAQ / Health Sciences Acquisitions Corp 2
NVAX / Novavax, Inc.
CCXI / ChemoCentryx Inc
STSA / Satsuma Pharmaceuticals Inc
PMVP / PMV Pharmaceuticals, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
CCCC / C4 Therapeutics, Inc.
KNTE / Kinnate Biopharma Inc.
ZGNX / Zogenix Inc
MCRB / Seres Therapeutics, Inc.
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
OCUL / Ocular Therapeutix, Inc.
TGTX / TG Therapeutics, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
CYT / Cyteir Therapeutics, Inc.
CNCE / Concert Pharmaceuticals Inc
DALS / DA32 Life Science Tech Acquisition Corp - Class A
TCRX / TScan Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.
BLSA / BCLS Acquisition Corp - Class A
RNA / Avidity Biosciences, Inc.
AADI / Aadi Bioscience, Inc.
KALA / KALA BIO, Inc.
SYRS / Syros Pharmaceuticals, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
FMTX / Forma Therapeutics Holdings Inc
WVE / Wave Life Sciences Ltd.
PCVX / Vaxcyte, Inc.
EWTX / Edgewise Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
DICE / DICE Therapeutics Inc
ATXS / Astria Therapeutics, Inc.
VOR / Vor Biopharma Inc.
MGNX / MacroGenics, Inc.
NKTX / Nkarta, Inc.
CLYM / Climb Bio, Inc.
ITOS / iTeos Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
BDTX / Black Diamond Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
ICVX / Icosavax, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.
GERN / Geron Corporation
AVTE / Aerovate Therapeutics, Inc.